230 Glucose, Glycated Hemoglobin A levels and Erectile Function in 16 Hypogonadal Men with Type 2 Diabetes (T2DM) before and after Testosterone Therapy

Abstract

Erectile function and glucose disposal deteriorate progressively in hypogonadal diabetic men, resulting in reduced quality of life. To compare glucose, glycated hemoglobin A (HbA1c) and erectile function in diabetic hypogonadal men who opted to remain untreated with testosterone (T) for long-term then commenced T treatment, based on medical advice by their cardiologists and urologists. Registry study of hypogonadal men in a urological office. Of 805 patients, 16 men who declined to undergo testosterone therapy (TTh) and experienced major cardiovascular adverse events (MACE) and lower urinary tract symptoms (LUTS) during 7 years of observation period. These men were then advised by their cardiologist and urologist to start TTh (TU 1000 mg/12 weeks). T levels were measured at trough levels right before the next injection. Glucose and HbA1c levels were measured at each visit and erectile function was assessed by the IIEF-EF, and quality of life by the aging male symptoms scale (AMS).